Medicare Enrolled
Dr. Karl Vogelbach, MD
Cardiovascular Disease · Arcadia, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vogelbach from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vogelbach?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vogelbach
Dr. Karl Vogelbach is a cardiovascular disease specialist in Arcadia, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Vogelbach performed 4,103 Medicare services across 2,479 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vogelbach received a total of $159,832 from 37 pharmaceutical and/or device companies across 724 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vogelbach is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 25% volume in CA
$159,832 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,103
Medicare services
Top 25% in CA for cardiovascular disease
2,479
Unique beneficiaries
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~216 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
823 | $98 | $225 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
637 | $74 | $155 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
496 | $7 | $10 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
372 | $43 | $125 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
223 | $22 | $75 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
181 | $12 | $65 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
156 | $162 | $700 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
146 | $66 | $135 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
126 | $95 | $300 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
121 | $58 | $200 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 116 | $408 | $600 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
104 | $18 | $50 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
100 | $10 | $50 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
66 | $29 | $100 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
63 | $404 | $1,600 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
58 | $1,685 | $2,700 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
58 | $122 | $250 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
54 | $119 | $300 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
47 | $41 | $95 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
33 | $47 | $125 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
29 | $156 | $550 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
28 | $109 | $275 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
27 | $68 | $120 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
20 | $188 | $750 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
19 | $160 | $500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.5% high complexity
19.7% medium
68.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$159,832
Total received (2018-2024)
Avg $22,833/year across 7 years
Top 4% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
724
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$150,302 (94.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,530 (6.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$19,887
2023
$30,115
2022
$15,830
2021
$10,117
2020
$9,314
2019
$31,399
2018
$43,170
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$18,477
Actelion Pharmaceuticals US, Inc.
$302
Edwards Lifesciences Corporation
$272
Merck Sharp & Dohme LLC
$157
Bayer Healthcare Pharmaceuticals Inc.
$144
Novartis Pharmaceuticals Corporation
$136
Boehringer Ingelheim Pharmaceuticals, Inc.
$87
E.R. Squibb & Sons, L.L.C.
$84
Lexicon Pharmaceuticals, Inc.
$67
PFIZER INC.
$54
Boston Scientific Corporation
$39
Amgen Inc.
$24
SCPHARMACEUTICALS INC.
$24
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$19
Top 3 companies account for 95.8% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$91,852
Amgen Inc.
$53,981
Novartis Pharmaceuticals Corporation
$5,546
Amarin Pharma Inc.
$946
Boehringer Ingelheim Pharmaceuticals, Inc.
$904
Esperion Therapeutics, Inc.
$752
AstraZeneca Pharmaceuticals LP
$646
Merck Sharp & Dohme LLC
$553
Bayer HealthCare Pharmaceuticals Inc.
$414
SANOFI-AVENTIS U.S. LLC
$400
Actelion Pharmaceuticals US, Inc.
$383
Bayer Healthcare Pharmaceuticals Inc.
$350
PFIZER INC.
$324
Lilly USA, LLC
$294
Edwards Lifesciences Corporation
$272
Cardiovascular Systems Inc.
$267
Medtronic Vascular, Inc.
$249
Novo Nordisk Inc
$239
Boston Scientific Corporation
$213
PORTOLA PHARMACEUTICALS, INC.
$198
Arbor Pharmaceuticals, Inc.
$151
Kiniksa Pharmaceuticals, Ltd.
$135
Abbott Laboratories
$123
Lexicon Pharmaceuticals, Inc.
$119
E.R. Squibb & Sons, L.L.C.
$84
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$79
ARBOR PHARMACEUTICALS, INC.
$52
United Therapeutics Corporation
$47
Gilead Sciences, Inc.
$37
Medicure Pharma Inc.
$36
Lundbeck LLC
$36
Kowa Pharmaceuticals America, Inc.
$35
Alnylam Pharmaceuticals Inc.
$29
Bardy Diagnostics, Inc.
$29
SCPHARMACEUTICALS INC.
$24
BOSTON SCIENTIFIC CORPORATION
$19
Glaukos Corporation
$13
Top 3 companies account for 94.7% of all-time payments
Associated products mentioned in payments ›
ACCOLADE · ANDEXXA · Adempas · Amplia MRI · Arcalyst · BEVYXXA · BRILINTA · BodyGuardian · CAMZYOS · CardioMEMS HF System · Carnation Ambulatory Monitor · Confirm Rx · Corlanor · Diamondback Peripheral · ELIQUIS · EMBLEM · EMGALITY · ENTRESTO · Edarbi · Edarbyclor · FARXIGA · FUROSCIX · Inpefa · JANUVIA · JARDIANCE · JOT DX · Kerendia · LEQVIO · LifeVest · Livalo · MOUNJARO · MULTAQ · Micra · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · ORENITRAM · Ozempic · PRADAXA · PRALUENT · RESONATE · RYBELSUS · Repatha · SAPIEN 3 Ultra RESILIA · SEGLENTIS · TRULICITY · TYVASO · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · Verquvo · XARELTO · ZYPITAMAG · Zypitamag · iStent Trabecular Micro-Bypass Stent System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (94%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for cardiovascular disease in CA.
Geographic Context
Cardiologists within 10 mi
510
Per 100K population
5.2
County median income
$87,760
Nearest hospital
USC ARCADIA HOSPITAL
1.3 mi
1.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Vogelbach is a clinical cardiology specialist, with above-average Medicare volume (top 25% in CA), with speaking/promotional industry engagement in the top 4% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Vogelbach experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Vogelbach performed 823 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vogelbach receive payments from pharmaceutical companies?
Yes. Dr. Vogelbach received a total of $159,832 from 37 companies across 724 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vogelbach's costs compare to other cardiologists in Arcadia?
Dr. Vogelbach's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vogelbach) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Arcadia
Browse cardiologists in Arcadia ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology